InvestorsHub Logo
Followers 0
Posts 386
Boards Moderated 0
Alias Born 09/26/2013

Re: None

Monday, 10/14/2013 12:16:07 PM

Monday, October 14, 2013 12:16:07 PM

Post# of 425824
SCAM BUSTED BY FDA SELL NOW RUN!!!!!NEW INVESTIGATIONS ANNOUNCED DAILY SELL SELL SELL SAVE YOUR MONEY


On October 11, 2013, Amarin shares fell more than 20% to close at $5.09 after the Food & Drug Administration released its briefing documents for the October 16, 2013 advisory committee review of Amarin’s application to expand the use of its drug Vascepa. The FDA briefing documents raised questions about the mineral oil placebo potentially negatively impacting the control group data and consequentially overstating Vascepa’s effectiveness.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News